» Articles » PMID: 33868980

Elevated Anxiety, Hypoactivity, Memory Deficits, Decreases of Brain Serotonin and 5-HT-1A Receptors Expression in Rats Treated with Omeprazole

Overview
Journal Toxicol Res
Specialty Toxicology
Date 2021 Apr 19
PMID 33868980
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Omeprazole (OM) is one of the most prescribed drugs worldwide for the treatment of hyperacidity and gastric reflux. However, concerns regarding its safety have emerged recently, and the drug is reported to enhance the risk for anxiety and cognitive deficits, particularly in elderly patients. The present study investigated these adverse effects, if any, in adult male rats. Associated changes in brain serotonin (5-hydroxytryptamine; 5-HT) and dopamine metabolism and the expression of 5-HT-1A receptors in the raphe and hippocampus were also determined. The drug was injected . in doses of 10 and 20 mg/kg for 15 days. Both doses of OM decreased motor activity in an open field and impaired learning and memory in the Morris water maze test. Anxiety monitored in an elevated plus maze test was enhanced in rats treated with 20 mg/kg OM only. The levels of 5-HT and its metabolite 5-hydroxyindoleacetic acid and of homovanillic acid, a metabolite of dopamine, determined by HPLC-EC, were decreased in the brain of OM treated rats. The expression of 5-HT-1A receptor, determined by qRT-PCR, was reduced markedly in the hippocampus and moderately in the raphe. Our results provide evidence that OM use can reduce raphe hippocampal serotonin neurotransmission to lead to anxiety/depression and cognitive impairment. There is a need for increased awareness and prescription guidelines for therapeutic use of OM and possibly also other proton pump inhibitors.

Citing Articles

Gallic acid alleviates omeprazole-induced depressive behavior and memory impairment.

Samad N, Manzoor N, Irfan A, Khalid A, Ejaz U, Abbas B Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39976720 DOI: 10.1007/s00210-025-03812-w.


Neuroprotective effect of niacin in a rat model of obesity induced by high-fat-rich diet.

Manzoor N, Samad N, Bhatti S, Irfan A, Ahmad S, Shazly G Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39680102 DOI: 10.1007/s00210-024-03687-3.


Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications.

Andriolo I, Longo B, de Melo D, de Souza M, Prediger R, da Silva L CNS Neurol Disord Drug Targets. 2024; 23(11):1371-1391.

PMID: 38500273 DOI: 10.2174/0118715273289138240306050532.


Long-term administration of omeprazole in mice: a study of behavior, inflammatory, and oxidative stress alterations with focus on central nervous system.

Coelho D, Costa Junior D, da Silva D, Alves A, Chaves R, Reboucas M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):6165-6175.

PMID: 38433146 DOI: 10.1007/s00210-024-03023-9.


Chronic Use of Proton Pump Inhibitors: A Potential Link to Amino Acid Deficiency and the Development of Depression.

Murthy J, Hughes S, Travis C, Chalia A, Khan S, Ang-Rabanes M Cureus. 2024; 15(12):e51067.

PMID: 38269224 PMC: 10807343. DOI: 10.7759/cureus.51067.


References
1.
Cheng F, Ho Y, Hung L, Chen C, Tsai T . Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. J Chromatogr A. 2002; 949(1-2):35-42. DOI: 10.1016/s0021-9673(01)01225-0. View

2.
Strasser B, Gostner J, Fuchs D . Mood, food, and cognition: role of tryptophan and serotonin. Curr Opin Clin Nutr Metab Care. 2015; 19(1):55-61. DOI: 10.1097/MCO.0000000000000237. View

3.
El-Shinnawy N, Abd-Elmageid S, Alshailabi E . Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats. Toxicol Ind Health. 2012; 30(4):357-75. DOI: 10.1177/0748233712457448. View

4.
Salman T, Nawaz S, Waraich R, Haleem D . Repeated administration of methylphenidate produces reinforcement and downregulates 5-HT-1A receptor expression in the nucleus accumbens. Life Sci. 2018; 218:139-146. DOI: 10.1016/j.lfs.2018.12.046. View

5.
Gomm W, von Holt K, Thome F, Broich K, Maier W, Fink A . Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol. 2016; 73(4):410-6. DOI: 10.1001/jamaneurol.2015.4791. View